Danny Hsu

Procaspase-3 Activation as an Anti-Cancer Strategy: Structure−Activity Relationship of Procaspase-Activating Compound 1 (PAC-1) and Its Cellular Co-Localization with Caspase-3

Quinn P. Peterson, Danny Hsu, David R. Goode et al. · Journal of Medicinal Chemistry · 2009 · 154 citations · Full text

Anti-cancer Strategy, Apoptosis, Immunology +16

Discovery and Canine Preclinical Assessment of a Nontoxic Procaspase-3–Activating Compound

Quinn P. Peterson, Danny Hsu, Chris J. Novotny et al. · Cancer Research · 2010 · 65 citations · Full text

Towards a species-selective acetylcholinesterase inhibitor to control the mosquito vector of malaria, Anopheles gambiae

Paul R. Carlier, Troy D. Anderson, Dawn M. Wong et al. · Chemico-Biological Interactions · 2008 · 55 citations

Species-selective Acetylcholinesterase Inhibitor, Vector Management, Biochemistry +10

Enantioselective Synthesis of Diversely Substituted Quaternary 1,4-Benzodiazepin-2-ones and 1,4-Benzodiazepine-2,5-diones

Paul R. Carlier, Hong‐Wu Zhao, Stephanie L. MacQuarrie‐Hunter et al. · Journal of the American Chemical Society · 2006 · 49 citations

Combinatorial Chemistry, Medicinal Chemistry, Bioorganic Chemistry +11

Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogs

Pamela Lucas, Joanna Schmit, Quinn P. Peterson et al. · Investigational New Drugs · 2010 · 47 citations · Full text

Medicine, Pharmacology, Healthy Dogs +5